Status: Recruiting
68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer
The goal of this observational study is to learn whether 68Ga-FAPI PET/CT may be used as a new effective methods for evaluating axillary lymph node efficacy after neoadjuvant treatment for breast cancer. The main question it aims to answer is: Could 68Ga-FAPI PET/CT effectively evaluate axillary lymph node after neoadjuvant treatment for breast cancer? Participants will have a 68Ga-FAPI PET/CT test between last neoadjuvant therapy and surgery.
Participants needed: 150
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Kunwei ShenUpdated: Dec 29, 2025Locations: 1
Eligibility criteria
Female patients aged 18 and above [+5]
Distant metastasis [+2]